Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the World's...

Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the
World's First Permanent, But Easier to Remove Tattoo Ink - in Australia and
New Zealand

CHERRY HILL, N.J., May 27 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC
Bulletin Board: NVLX), an emerging healthcare consumer products company, today
announces Jayhur Enterprises will distribute Infinitink (the world's first
permanent tattoo ink designed for easier removal) in Australia and New
Zealand.

The distribution agreement grants Jayhur Enterprises (Sydney, Australia) a
five-year, exclusive contract to market, promote, market, distribute and sell
Infinitink in the high potential markets of Australia and New Zealand.

Based on the age of the population and popularity of tattoos in Australia
alone, Nuvilex estimates that if Jayhur Enterprises captures 30% of today's
market by the end of the agreement, the annual revenue could be as high as
$3.75MM. In addition, if trends hold from the US, 15% of Australia's
population over 15 years of age is considering a tattoo, but have reservations
due to the permanence of the art form. These 'fence sitters' are excellent
candidates for artists offering Infinitink tattoos.

"We are very pleased to begin distribution of Infinitink in Australia and New
Zealand," said Martin E. Schmieg, Chairman and CEO of Nuvilex, Inc. "We
believe the region offers an excellent opportunity for Infinitink sales, and
we look forward to working with Jayden Hurvitz and his team at Jayhur
Enterprises."

Jayhur Enterprises joins with MT.Derm, GmbH, Berlin, Germany as Infinitink
international distributors. MT.Derm owns Infinitink European distribution
rights and since 2006 has been a development partner with Freedom2. Nuvilex is
seeking a distributor for Latin and South America.

About Infinitink
Infinitink is the result of advanced research by physician scientists at
Harvard, Duke and Brown Universities. Infinitink is a high quality tattoo ink
engineered to enable more effective laser tattoo removal. The removability
feature reduces the cost and discomfort for consumers wishing to remove or
change an Infinitink tattoo. Created from high-quality materials, Infinitink
meets EU and California 65 proposition regulations and is manufactured under
strict quality standards designed to meet rigorous pharmaceutical industry
standards.

About Nuvilex, Inc.
Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products
company with a portfolio of aesthetics, dermatology, environmental and
nutraceutical products. The company's focus is on developing, licensing and
commercializing healthcare products that address the health needs of consumers
worldwide. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., a
diversified skin products technology company serving the fast-growing body
art, aesthetic, cosmetic and skin therapy markets. More information is
available at: http://www.nuvilex.com or www.freedom2inc.com.

Safe Harbor Statement
Statements contained in this presentation that are not strictly historical are
"forward-looking" statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities and Exchange Act of
1934. The forward-looking statements are made based on information available
as of the date hereof, and the Company assumes no obligation to update such
forward-looking statements. Forward-looking statements are sometimes
identified by words such as "intends", "anticipates", "believes", "expects",
and "hopes" and involve a number of risks and uncertainties that could cause
the Company's actual results to differ materially from projected results. All
parties are cautioned that such forward-looking statements involve risks and
uncertainties that could cause the Company's actual results to differ
materially from those in these forward-looking statements. Such risks and
uncertainties include but are not limited to demand for the Company's products
and services, the planned share exchange with Freedom2 Holdings, Inc., our
ability to secure additional financing, and other factors that may be more
fully described in reports to shareholders and periodic filings with the
Securities and Exchange Commission.

Investor Relations Contacts:

Blair Barnes
Senior Vice President and Chief Financial Officer
Nuvilex, Inc.
Ph: 856-433-6088
Email: bbarnes@nuvilex.com

Stephanie Carrington/Amy Glynn
The Ruth Group
Ph: 646-536-7017/7023
Email: scarrington@theruthgroup.com
Email: aglynn@theruthgroup.com

Press Contact:

Pat Arcand
Arcand & Madison
Ph: 617-576-7777
Email: pat@am-pr.com

SOURCE Nuvilex, Inc.

Investor Relations, Blair Barnes, Senior Vice President and Chief Financial
Officer of Nuvilex, Inc., +1-856-433-6088, bbarnes@nuvilex.com; or Stephanie
Carrington, +1-646-536-7017, scarrington@theruthgroup.com, or Amy Glynn,
+1-646-536-7023, aglynn@theruthgroup.com, both of The Ruth Group; or Press,
Pat Arcand of Arcand & Madison, +1-617-576-7777, pat@am-pr.com